Skip to main content
. 2021 Apr 14;10(8):1684. doi: 10.3390/jcm10081684

Table 3.

Adverse events.

Adverse Events n (%)
• Thrombocytopenia ≥ G4 45 (95.7%)
• Neutropenia ≥ G4 47 (100%)
• Febrile neutropenia 21 (45%)
• Anemia ≥ G3 45 (95.7%)
• Infections 17 (36%)
• Mucositis 10 (21%)
• Tumor lysis syndrome 0